poisar

Stocks · News reference

PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M Estimate

Aug 4, 2026, 8:06 PMBenzinga Newsdesk

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.46) by 2.17 percent. This is a 34.29 percent decrease over losses of $(0.35) per share

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

PRCT
Source
benzinga
Observed
Aug 4, 2026, 8:06 PM
Checked
Aug 4, 2026, 8:06 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 18, 2026, 10:11 PMBrendan Coffey

    Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?

    Procept BioRobotics CEO Larry Wood purchased 23,900 shares (~$498,000) through a trust on August 7, 2026, expanding his beneficial stake to 338,103 shares. The purchase occurred as the stock declined 48% over the past year, but comes after the company reported 19% Q2 sales growth and Wood's reorganization efforts. Insider purchases are typically viewed as bullish signals, suggesting management confidence in the company's turnaround prospects despite ongoing net losses of $109.8 million on $337.3 million in trailing revenue.

    Read original at the-motley-fool
    PRCT
  2. Aug 7, 2026, 2:45 PMKaplan Fox & Kilsheimer Llp

    Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors with Significant Losses to Contact the Firm Before September 22, 2026

    Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against PROCEPT BioRobotics Corporation for allegedly using undisclosed discount programs that artificially inflated handpiece unit sales and revenues during the Class Period (February 28, 2024 - February 25, 2026). The firm is also pursuing cases against Hub Group, Inc. and investigating potential securities violations at Alignment Healthcare, Inc. Investors with losses are encouraged to contact the firm before respective deadlines.

    Read original at globenewswire-inc
    PRCTHUBGALHC